Novak Djokovic holds 80% of Danish biotech creating Covid-19 therapy: CEO
Tennis champion Novak Djokovic has an 80% stake of Danish biotech agency QuantBioRes, which is aiming to develop a medical therapy to counter COVID-19, the corporate’s chief government informed Reuters on Wednesday.
CEO Ivan Loncarevic, who described himself as an entrepreneur, stated the funding was made in June 2020 however declined to say how a lot it was.
QuantBioRes has round 11 researchers working in Denmark, Australia and Slovenia, in keeping with Loncarevic, who harassed they had been engaged on a therapy, not a vaccine.
The firm is creating a peptide, which inhibits the coronavirus from infecting the human cell, expects to launch medical trials in Britain this summer time, he added.
A spokesperson for Djokovic didn’t instantly reply to a request for remark.
The tennis primary has stoked world debate concerning the rights of people that decide to not get vaccinated after he was deported from Australia on Sunday evening, ruling him out of the Australian Open.
